Management of the COPD Patient with Comorbidities: An Experts Recommendation Document
Received 11 December 2019
Accepted for publication 10 March 2020
Published 7 May 2020 Volume 2020:15 Pages 1015—1037
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Richard Russell
Jesús Recio Iglesias,1 Jesús Díez-Manglano,2 Francisco López García,3 José Antonio Díaz Peromingo,4 Pere Almagro,5 José Manuel Varela Aguilar6,7
1Internal Medicine Department, Quironsalud Valencia Hospital, Valencia, Valencian Community, Spain; 2Internal Medicine Department, Royo Villanova Hospital, Zaragoza, Aragon, Spain; 3Internal Medicine Department General University Hospital of Elche, Alicante, Valencian Community, Spain; 4Internal Medicine Department, University Clinical Hospital of Santiago de Compostela, a Coruña, Galicia, Spain; 5Internal Medicine Department, Mútua Terrassa University Hospital, Terrassa, Barcelona, Catalonia, Spain; 6Internal Medicine Department, University Hospital Virgen del Rocío, Seville, Andalusia, Spain; 7CIBER of Epidemiology and Public Health, Madrid, Community of Madrid, Spain
Correspondence: Jesús Recio Iglesias
Internal Medicine Department, Quironsalud Valencia Hospital, Avenida Blasco Ibañez 14, Valencia, Valencian Community 46010, Spain
Tel +34 963690600
Fax +34 961041646
Background: Chronic obstructive pulmonary disease (COPD) is associated with multiple comorbidities, which impact negatively on patients and are often underdiagnosed, thus lacking a proper management due to the absence of clear guidelines.
Purpose: To elaborate expert recommendations aimed to help healthcare professionals to provide the right care for treating COPD patients with comorbidities.
Methods: A modified RAND-UCLA appropriateness method consisting of nominal groups to draw up consensus recommendations (6 Spanish experts) and 2-Delphi rounds to validate them (23 Spanish experts) was performed.
Results: A panel of Spanish internal medicine experts reached consensus on 73 recommendations and 81 conclusions on the clinical consequences of the presence of comorbidities. In general, the experts reached consensus on the issues raised with regard to cardiovascular comorbidity and metabolic disorders. Consensus was reached on the use of selective serotonin reuptake inhibitors in cases of depression and the usefulness of referring patients with anxiety to respiratory rehabilitation programmes. The results also showed consensus on the usefulness of investigating the quality of sleep, the treatment of pain with opioids and the evaluation of osteoporosis by lateral chest radiography.
Conclusion: This study provides conclusions and recommendations that are intended to improve the management of the complexity of patients with COPD and important comorbidities, usually excluded from clinical trials.
Keywords: chronic obstructive pulmonary disease, COPD, comorbidities, modified RAND-UCLA, Delphi technique
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]